药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Iron Dextran
Saralasin
The risk or severity of hyperkalemia can be increased when Mibefradil is combined with Saralasin.
Iron Dextran
Danaparoid
The risk or severity of hyperkalemia can be increased when Mibefradil is combined with Danaparoid.
Iron Dextran
Sulodexide
The risk or severity of hyperkalemia can be increased when Mibefradil is combined with Sulodexide.
Iron Dextran
Penicillin G Acyl-Serine
The risk or severity of hyperkalemia can be increased when Mibefradil is combined with Penicillin G Acyl-Serine.
Iron Dextran
Saprisartan
The risk or severity of hyperkalemia can be increased when Saprisartan is combined with Mibefradil.
Iron Dextran
Forasartan
The risk or severity of hyperkalemia can be increased when Forasartan is combined with Mibefradil.
Iron Dextran
Enoxaparin
The risk or severity of hyperkalemia can be increased when Enoxaparin is combined with Mibefradil.
Iron Dextran
Rescinnamine
The risk or severity of hyperkalemia can be increased when Rescinnamine is combined with Mibefradil.
Iron Dextran
Heparin
The risk or severity of hyperkalemia can be increased when Heparin is combined with Mibefradil.
Iron Dextran
Irbesartan
The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Mibefradil.
Iron Dextran
Fingolimod
Mibefradil may increase the bradycardic activities of Fingolimod.
Iron Dextran
Rivastigmine
Rivastigmine may increase the bradycardic activities of Mibefradil.
Iron Dextran
Poractant alfa
Mibefradil may increase the bradycardic activities of Poractant alfa.
Iron Dextran
Lanreotide
Mibefradil may increase the bradycardic activities of Lanreotide.
Iron Dextran
Beractant
Mibefradil may increase the bradycardic activities of Beractant.
Iron Dextran
Calfactant
Mibefradil may increase the bradycardic activities of Calfactant.
Iron Dextran
Lucinactant
Mibefradil may increase the bradycardic activities of Lucinactant.
Iron Dextran
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Mibefradil.
Iron Dextran
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Mibefradil.
Iron Dextran
Rilpivirine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Mibefradil.